Concepedia

Dooseop Kim

DK

25

Publications

2.9K

Citations

23

H-Index

1985

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

University of Pittsburgh

Dooseop Kim is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1985–2010

25

Publications

25

(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Dooseop Kim, Liping Wang, Maria Beconi et al. · Journal of Medicinal Chemistry · 2004 · 808 citations · Full text

Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes

George R. Lankas, Barbara Leiting, Ranabir Sinha Roy et al. · Diabetes · 2005 · 490 citations · Full text

, , +15

Translocation of radical sites by intramolecular 1,5-hydrogen atom transfer

Dennis P. Curran, Dooseop Kim, Hong Tao. Liu et al. · Journal of the American Chemical Society · 1988 · 196 citations

, , +14

Potent, orally absorbed glucagon receptor antagonists

Stephen E. de Laszlo, Candice Hacker, Bing Li et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 169 citations · Full text

, , +5

Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties

Dooseop Kim, Liping Wang, Jeffrey J. Hale et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 148 citations · Full text

, , +11

Rows per page

1–5 of 25